AUSTIN, Texas, May 11, 2015 (GLOBE NEWSWIRE) -- LDR Holding Corporation (Nasdaq:LDRH), a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders, today announced that Christophe Lavigne, President and Chief Executive Officer, and Robert McNamara, Executive Vice President and Chief Financial Officer, will be presenting at the UBS Global Healthcare Conference to be held on May 18, 2015 to May 20, 2015 in New York. LDR Holding's presentation will take place on Monday, May 18, 2015 at 11:00 AM Eastern Time.
The presentation will also be broadcast live over the Internet and can be accessed on the Investors section of the Company's website at www.ldr.com. For those who are not available to listen to the live webcast, the presentation will be archived for 90 days on LDR's website.
About LDR Holding Corporation
LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and proprietary surgical technologies for the treatment of patients suffering from spine disorders. LDR's primary products are based on its exclusive VerteBRIDGE® fusion and Mobi non-fusion technology platforms and are designed for applications in the cervical and lumbar spine. These technologies are designed to enable products that are less invasive, provide greater intra-operative flexibility, offer simplified surgical techniques and promote improved clinical outcomes for patients as compared to existing alternatives. In August 2013, LDR received approval from the U.S. Food and Drug Administration (FDA) for the Mobi-C cervical disc replacement device, the first and only cervical disc replacement device to receive FDA approval to treat both one-level and two-level cervical disc disease. For more information regarding LDR Holding, visit www.ldr.com.